Follow-Up on BIO’s Comments in Response to the ICER Value Framework

BIO Applauds Senators Heitkamp, Heller and Peters for Introducing the SEC Small Business Advocate Act

Bill would enhance the voice of emerging companies at the SEC

BIO Collaborates with NIH and NSF on Growing “Innovation Zone” at BIO 2016 International Convention

The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in an expanded Innovation Zone at the 2016 BIO International Convention. 

BIO Statement on USTR’s 2016 “Special 301 Report”

The Biotechnology Innovation Organization (BIO) released the following statement regarding The Office of the United States Trade Representative’s (USTR) 2016 Special 301 Report:

The 2016 BIO World Congress on Industrial Biotechnology Closed with a Record Number of Partnering Meetings

This year’s Conference drew around 907 industry leaders from 529 companies, 32 countries and 31 states, as well as the District of Columbia. Organized by the Biotechnology Innovation Organization (BIO), the World Congress on Industrial Biotechnology hosted more than 1,961 partnering meetings, nearly a 40% increase from the 2015 BIO World Congress.

CSRxP Plan Fails to Tackle Real Drivers of Consumer Out of Pocket Costs

The Biotechnology Innovation Organization (BIO) issued the following statement today regarding the Campaign for Sustainable Rx Pricing’s policy proposals on prescription drug prices:

BIO Presents Dr. Ganesh Kishore New Award for Leadership and Legacy in Industrial Biotechnology

BIO presented Dr. Ganesh Kishore, CEO, MLSCFI and co-Managing Partner, Spruce Capital Partners, the first annual BIO Leadership and Legacy Award today during BIO’s 13th Annual World Congress on Industrial Biotechnology. The new award was created to honor an individual who has shown exemplary leadership and who has dedicated a significant portion of their career to advancing industrial biotechnology and growing the biobased economy.

Kentucky Governor Bevin Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

The Biotechnology Innovation Organization (BIO) and Kentucky Life Science Council (KLSC) commend Governor Matt Bevin for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

Media Advisory: NexSteppe CEO Anna Rath to Receive BIO Award Honoring an Outstanding Woman in Industrial Biotechnology

President and CEO of NexSteppe Anna Rath will deliver remarks and will be presented the Rosalind Franklin Award by the Biotechnology Innovation Organization (BIO) at the 2016 World Congress on Industrial Biotechnology in San Diego on Tuesday April 19.

Representative Meehan Honored as BIO Legislator of the Year

The Biotechnology Innovation Organization (BIO) announced today its selection of Congressman Patrick Meehan (R-PA) as a Legislator of the Year for 2016. Representative Meehan receives the award in conjunction with today’s BIO Legislative Day Fly-In.